 So, we invite to the stage Tony Rose Hallower, Emily Senna and Emily Stegman. If they are here, all of you? OK, excellent. And they will be talking about a series, TS2 and Iris, introducing my new EC-funded initiative to boost the reproducibility of research. The stage is yours. Thank you. So, I'm Tony Rose Hallower from TU Gratz and with us Professor Emily Senna and Associate Professor Inge Stegman of Edinburgh University and New Trek University. We don't have any really cool findings to share with you today. What we want to share with you today, which is really cool, is that we've got a bunch of money to study a lot of really cool things with some really cool people. So, we're just going to run through that and then if you want to find out more, maybe you can come and talk with us over coffee or lunch. We don't need to go through this, so we'll talk about reproducibility here in a very, very broad sense. Similar or same methods to reach similar conclusions, so not distinguishing conceptual reproducibility from computational or so on. But we know from everything that we've heard in the conference that there are a lot of issues that lead to lack of reproducibility at the moment and that this is perceived as a real problem, especially in certain disciplines. So, three years ago, the European Commission, Commission of the Scoping Report to Merrington from COS was one of the co-authors of this and this recommended certain lines, including dedicated funding lines, testing and scaling of interventions, capacity building and alignment of policies. And so, this led to a specific call from the European Commission on the theme of increasing the reproducibility of scientific results. Two projects were to be funded, although in the end three were. And Inga, Emily and I are the kind of three principles responsible for those bids. And so, although the calls kind of overlapped in some ways and our projects overlapped, we wanted to make sure that we find synergies wherever possible to maximise the kind of return on investment. As Emily said in her talk today, meta-science research, there's not a lot of dedicated funding lines and so there's no point in doing the same thing twice unless of course it's for triangulation. So, just to talk about my project, tier two, this began in January 23, the start of this year and runs to December 2025. Kind of one of the key elements of our project is that we want to centre the concept of epistemic diversity. I mean, reproducibility doesn't mean the same things across different disciplines and maybe isn't applicable or is much less applicable as a theme once you get towards certain types of qualitative research or into the humanities. So, we centre epistemic diversity and investigate reproducibility, especially in social life computer scientists, computer sciences, plus the funder in the publisher context. We have this idea of treating reproducibility as a full-stack problem so we all know the pyramid, the strategy for culture change from the Centre for Open Science, which is that we need to work across all these various levels of intervention to achieve research reform and we need to do so in a holistic way and a strategic way. We'll use very co-creative approaches to creating and evaluating new reproducibility tools and practices, so this means we'll be doing a bunch of workshops and co-creation events with funders, publishers and researchers over the coming years. A key aim is to boost capacity, especially through building on the fantastic work which has already been done at grassroots level to set up the reproducibility networks. So, we will have a call, it should be open just before summer, especially for kind of widening participation countries within the EU. So, these are countries from, especially from the former Eastern Bloc, to create new reproducibility networks, but also look at ways to link these kind of grassroots initiatives with more top-down initiatives like the European Open Science Cloud from the EC. A bunch of great partners, of course, and then... So, as Tanya mentioned, I was the PI for IRISE, but Brexit is still daunting us, so thankfully our colleagues in Charité are the official now leaders of the IRISE consortium, improving reproducibility in science. We're due to start in September, so this is just hot off the press, we only signed our grant agreement a few weeks ago, and our aims are to provide a richer and deeper understanding of the drivers of poor reproducibility and to conduct a detailed evaluation, including actually conducting some primary research studies of the effectiveness of interventions to increase reproducibility. And the way that we've set the project up is really in two halves. We've got the kind of toolbox half, where we're going to provide theoretical evidence, so we're working with some economists to provide evidence describing the effectiveness of specific interventions, and then we're also going to produce some empirical evidence, like I said, to conduct some primary research, testing interventions to see how they improve reproducibility. And then we're going to use that toolbox to propose a framework for robust evidence-based roadmap for how you develop interventions to improve reproducibility, how you assess their effectiveness, and also how you implement them. And then alongside the project, we've also got a... I can't remember what the work package is called now, but essentially a DEI work package to ensure that we also, following from the session before, that we include some of these aspects to ensure that we're not marginalising people as we develop and implement new interventions. And we have a range of partners there on the right of the screen. Thank you. So for Osiris, Osiris started with Mariska Leivlang from the Amsterdam UMC and myself being intrigued by the fact that we are clinical researchers and doing a lot of research on patients, in which we are actually doing RCTs, randomized patients to different treatments. And we were intrigued by the fact that most of the open science interventions and reproducibility interventions are not really tested in that way. Well, for many of those, there's not a real reason not to do so. So that's when we started Osiris. And what we basically want to do is to first understand the underlying drivers and effective interventions that increase reproducibility. And we divided our project in interventions for funders, for universities, and for researchers, and for journals, actually, that's not on this. So that's the first part of our project and we're actually doing a scoping review for that and a couple of other different reviews. And that scoping review is also the first part of our collaboration with IRISE and Tier 2. So we're now doing that and actually hoping that we get the outcomes in the coming months. So to the core of our project is the development of effective and evidence-based solutions for increasing reproducibility. So after the scoping review, we will test the interventions that we find in the scoping review on their effectiveness with randomized controlled trials or observational studies if needed. But as much as possible with randomized controlled trials. And again, we divided that in work packages, specifically for funders, for journals, and for institutions. Once we've done this, we want to embed this in the design of research projects and we want to create a community of stakeholders. So our collaboration. Well, I think the first success of this collaboration is that we're actually able to present three projects in 10 minutes. So that's... I'd say that we started off pretty nicely here. The first thing we want to do is the evidence... The scoping interventions for... The scoping review for interventions that are already out there. And we've already started that because that deliverable is actually due in a couple of months. And it's basically the core, I think, of many of our projects is we really need that information before we can continue. So that work has already started and is going pretty nicely. We want to develop metrics and indications. And we want to also collaborate on the level of funders and publishers and journals so that we don't bother them with all our different interventions and the different trials we want to test. But we really want to collaborate on that part as well. And I think that we also hope that if there's other projects that also want to collaborate in that, that would be very useful because that might help in doing this a bit more effective. We will create events and do community building. We've already submitted a grant to try to get extra money for that. And we do self-reflection on our own practices. For Osiris, we want to do an audit. And in Tier 2, I always forget what you call it. Auto ethnography. Thank you so much for that. That's also impossible for a Dutch person to pronounce. So we will try to combine those ideas about how we can actually, I will say audit, the interventions, the work that we're actually doing. So we hope that at the end of our projects we also have some sort of guidelines for larger projects on how you can actually audit your own reproducibility within your project. And of course we will design tools and interventions, an observatory and a website in which you can find all the information and everything we will be doing. This is the information, our contact information. Please contact us because I think we started off pretty nicely with this collaboration now. We already have started with doing the research and doing the job. And I think it's important and I think we think it's important for our community to really get together because we will be way more effective in the research we're doing this way. Thank you for that.